Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132091 · ClinicalTrials.gov registry record · NA
Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT02132091 is a NA study that has completed, run by University of Florida. The registered enrollment target is 37 participants.
The verdict
NCT02132091, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Healthy volunteers will be recruited to participate in a ten-week double-blinded crossover trial. The trial will consist of two, three-week periods of intermittent fasting, where subjects receive either antioxidant supplementation or placebo, the ordering of which will be randomly determined. A one-week preconditioning will precede each invention period, and a two week "wash-out" period will follow the first intervention period. Serum-based assays will be performed to assess levels of reactive oxidant species, antioxidant genes, sirtuins, and markers of mitochondrial biogenesis and aging. The investigators hypothesize that an intermittent fasting diet in healthy young volunteers will improve these markers of cellular aging and that these beneficial effects will be abrogated by the supplementation of antioxidants. This study is a proof-of-principle study that will shed light on the mechanism and effects of IF as an anti-aging dietary intervention in the absence of weight loss. It will inform the design of dietary interventions that are both effective in improving markers of aging and feasible for patients to practice on a long-term basis.
Interventions
- OTHER Intermittent Fasting
- DIETARY_SUPPLEMENT 400 IU Vitamin E
- DIETARY_SUPPLEMENT 1000 mg Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02132091
The ClinicalTrials.gov registry entry for NCT02132091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intermittent Fasting is the first listed.
NCT02132091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02132091 about?
NCT02132091 is a clinical study titled "Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress". Healthy volunteers will be recruited to participate in a ten-week double-blinded crossover trial. The trial will consist of two, three-week periods of intermittent fasting, where subjects receive either antioxidant supplementation or placebo, the ordering of which will be randomly determined. A one-...
What is the current status of trial NCT02132091?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2011-03. Estimated completion is 2011-11.
What interventions are being tested in trial NCT02132091?
The interventions under investigation include: Intermittent Fasting (OTHER), 400 IU Vitamin E (DIETARY_SUPPLEMENT), 1000 mg Vitamin C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02132091?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.